Anti-Cytokeratin 8 (phospho S23) antibody [EP1629Y]
- BOND RX™ Validated
- RabMAb
- Recombinant
- 각 태그의 뜻
Be the first to review this product! 리뷰 제출
|
(3 제품이 사용된 논문 )
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 8 (phospho S23) antibody [EP1629Y] (AB76584)
Immunohistochemical analysis of paraffin-embedded Human stomach tissue labeling Cytokeratin 8 with ab76584 at 1/3600 dilution (0.035 µg/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). The section was incubated with ab76584 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0 epitope retrieval solution 2) for 20 mins.
- WB
Supplier Data
Western blot - Anti-Cytokeratin 8 (phospho S23) antibody [EP1629Y] (AB76584)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Cytokeratin 8 (phospho S23) antibody [EP1629Y] (ab76584) at 1/10000 dilution
Lane 1:
Untreated HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate at 15 µg
Lane 2:
HeLa treated with 100nM Calyculin A for 30mins whole cell lysate at 15 µg
Lane 3:
HeLa treated with 100nM Calyculin A for 30mins whole cell lysate, then the membrane treated with Alkaline Phosphatase for 1 hour at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 54 kDa
Observed band size: 54 kDa
false
Exposure time: 7s
- Dot
Supplier Data
Dot Blot - Anti-Cytokeratin 8 (phospho S23) antibody [EP1629Y] (AB76584)
Dot blot analysis of Cytokeratin 8 (phospho S23) using ab76584 at 1/1000 dilution, followed by a Goat Anti-Rabbit IgG (H+L) Peroxidase conjugated (ab97051) at 1/100,000 dilution. Blocking and dilution buffer : 5% NFDM/TBST. Exposure time : 180s.
All lanes:
Dot Blot - Anti-Cytokeratin 8 (phospho S23) antibody [EP1629Y] (ab76584) at 1/1000 dilution
Lane 1:
Cytokeratin 8 (phospho S23) peptide
Lane 2:
EGFR non-phospho peptide
Secondary
All lanes:
Dot Blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
false
Exposure time: 180s
관련 conjugated 항체와 다양한 조성의 항체 (1)
-
Anti-Cytokeratin 8 (phospho S23) antibody [EP1629Y] - BSA and Azide free
Reactivity 정보
제품 세부 정보
This product has switched from a hybridoma to recombinant production method on 23rd February 2024.
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
대체 명칭 보기
제품이 사용된 논문 (3)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Developmental cell 59:2347-2363.e9 PubMed38843837
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 6:26557 PubMed27222304
2016
Applications
Unspecified application
Species
Unspecified reactive species
Toxicology and applied pharmacology 238:71-9 PubMed19409407
2009
Applications
IHC-Fr
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com